DE69330809D1 - Therapeutisches Agens für Neutropenie - Google Patents

Therapeutisches Agens für Neutropenie

Info

Publication number
DE69330809D1
DE69330809D1 DE69330809T DE69330809T DE69330809D1 DE 69330809 D1 DE69330809 D1 DE 69330809D1 DE 69330809 T DE69330809 T DE 69330809T DE 69330809 T DE69330809 T DE 69330809T DE 69330809 D1 DE69330809 D1 DE 69330809D1
Authority
DE
Germany
Prior art keywords
neutropenia
treatment
pharmaceutical compositions
therapeutic agent
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69330809T
Other languages
English (en)
Other versions
DE69330809T2 (de
Inventor
Tatsuya Watanabe
Sumie Yoshitomi
Sasada Reiko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69330809D1 publication Critical patent/DE69330809D1/de
Application granted granted Critical
Publication of DE69330809T2 publication Critical patent/DE69330809T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69330809T 1992-06-08 1993-06-04 Therapeutisches Agens für Neutropenie Expired - Lifetime DE69330809T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14774992 1992-06-08

Publications (2)

Publication Number Publication Date
DE69330809D1 true DE69330809D1 (de) 2001-10-31
DE69330809T2 DE69330809T2 (de) 2002-05-16

Family

ID=15437279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330809T Expired - Lifetime DE69330809T2 (de) 1992-06-08 1993-06-04 Therapeutisches Agens für Neutropenie

Country Status (5)

Country Link
US (1) US6015552A (de)
EP (1) EP0573904B1 (de)
AT (1) ATE206056T1 (de)
CA (1) CA2097878C (de)
DE (1) DE69330809T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1292680T3 (da) * 2000-06-22 2010-03-08 Genentech Inc Agonist-anti-TrkC monoklonale antistoffer
ATE411038T1 (de) 2003-03-28 2008-10-15 Univ Laval S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
CN1897977A (zh) * 2003-10-20 2007-01-17 Ns基因公司 帕金森氏病的体内基因治疗
CN107286233B (zh) * 2016-04-13 2020-11-06 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
US5288487A (en) * 1989-02-28 1994-02-22 Morinaga Milk Industry Co., Ltd. Human monocyte-macrophage-CSF preparations
US6709837B1 (en) * 1989-03-10 2004-03-23 Takeda Chemical Industries, Inc. Polypeptide and production thereof
GR1000980B (el) * 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
IT1239271B (it) * 1990-02-27 1993-10-01 Fidia Spa Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5488099A (en) * 1992-03-06 1996-01-30 Persson, Deceased; Hakan B. Multifunctional chimeric neurotrophic factors

Also Published As

Publication number Publication date
CA2097878C (en) 2006-08-22
EP0573904B1 (de) 2001-09-26
CA2097878A1 (en) 1993-12-09
EP0573904A1 (de) 1993-12-15
US6015552A (en) 2000-01-18
DE69330809T2 (de) 2002-05-16
ATE206056T1 (de) 2001-10-15

Similar Documents

Publication Publication Date Title
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DE69835435D1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
DE69330809D1 (de) Therapeutisches Agens für Neutropenie
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE60028559D1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE131382T1 (de) Mittel zur topischen behandlung von verbrennungen
SU1553129A1 (ru) Способ лечени альгоменореи
KR890001555A (ko) 요산 배설용 조성물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP